Inventor · disambiguated record
Andrew Chan
Also filed as: CHAN ANDREW · CHAN ANDREW C · CHAN ANDREW CHEE-YUEN
12 granted patents·19 pending applications·473 citations·filing 1997–2021
93Inventor score
Top patents by PatentIndex Score
31 records- 0198US7799900B2Immunoglobulin variants and uses thereofGENENTECH INC·Filed 2005·Granted Sep 21, 2010·103 cites·19 claims
- 0297US8562992B2Immunoglobulin variants and uses thereofADAMS CAMELLIA W·Filed 2008·Granted Oct 22, 2013·69 cites·6 claims
- 0397US7662926B2Anti-Fc-gamma receptor antibodies, bispecific variants and uses thereforGENENTECH INC·Filed 2007·Granted Feb 16, 2010·85 cites·39 claims
- 0496USRE46534EComposition and methods for the diagnosis of immune related diseases involving the PRO52254 polypeptideGENENTECH INC·Filed 2015·Granted Sep 5, 2017·32 cites·37 claims
- 0594US8071097B2Apoptotic anti-IgE antibodiesWU LAWREN·Filed 2008·Granted Dec 6, 2011·34 cites·64 claims
- 0694US7655229B2Anti-FC-gamma RIIB receptor antibody and uses thereforCHAN ANDREW C·Filed 2007·Granted Feb 2, 2010·93 cites·40 claims
- 0791USRE46805EComposition and methods for the diagnosis of immune related diseases involving the PRO52254 polypeptideGENENTECH INC·Filed 2014·Granted Apr 24, 2018·14 cites·27 claims
- 0890USRE46816EComposition and methods for the diagnosis of immune related diseases involving the PRO52254 polypeptideGENENTECH INC·Filed 2014·Granted May 1, 2018·12 cites·27 claims
- 0986US7402728B2Transgenic mice expressing human CD20 and/or CD16GENENTECH INC·Filed 2003·Granted Jul 22, 2008·25 cites·23 claims
- 1082US8632775B2Apoptotic anti-IgE antibodiesWU LAWREN·Filed 2011·Granted Jan 21, 2014·4 cites·7 claims
- 1176US2022002430A1Immunoglobulin variants and uses thereofGENENTECH INC·Filed 2021·Application pending·0 cites
- 1265US2010143352A1Combination therapy for b cell disordersGENENTECH INC·Filed 2009·Application pending·0 cites
- 1365US2019071511A1Immunoglobulin variants and uses thereofGENENTECH INC·Filed 2018·Application pending·0 cites
- 1463US2014154242A1Immunoglobulin variants and uses thereofGENENTECH INC·Filed 2013·Application pending·0 cites
- 1561US2014115729A1Apoptotic anti-ige antibodiesGENENTECH INC·Filed 2013·Application pending·0 cites
- 1661US2017158773A1Immunoglobulin variants and uses thereofGENENTECH INC·Filed 2016·Application pending·0 cites
- 1761US2009181024A1Novel composition and methods for the treatment of immune related diseasesGENENTECH INC·Filed 2006·Application pending·0 cites
- 1859US2014377257A1Combination therapy for b cell disordersGENENTECH INC·Filed 2014·Application pending·0 cites
- 1959US2006024300A1Immunoglobulin variants and uses thereofGENENTECH INC·Filed 2005·Application pending·0 cites
- 2057US2006135430A1BLy antagonists and uses thereofGENENTECH INC·Filed 2005·Application pending·0 cites
- 2156US2004121370A1Novel composition and methods for the treatment of immune related diseasesGENENTECH INC·Filed 2003·Application pending·0 cites
- 2256US2008095771A1Treatment MethodGENENTECH INC·Filed 2007·Application pending·0 cites
- 2355US2005095243A1Combination therapy for B cell disordersGENENTECH INC·Filed 2004·Application pending·0 cites
- 2455US2008299117A1Treatment MethodBARRON HAL V·Filed 2008·Application pending·0 cites
- 2553US2008075719A1Method for Augmenting B Cell DepletionGENENTECH INC·Filed 2007·Application pending·0 cites
- 2651US2006188495A1Treatment methodGENENTECH INC·Filed 2006·Application pending·0 cites
- 2747US2005276803A1Method for augmenting B cell depletionGENENTECH INC·Filed 2005·Application pending·0 cites
- 2846US2005163775A1Combination therapy for B cell disordersGENENTECH INC·Filed 2004·Application pending·0 cites
- 2941US2006073142A1Anti-Fc-gamma RIIB receptor antibody and uses thereforGENENTECH INC·Filed 2005·Application pending·0 cites
- 3038US5994522ABLNK proteinsUNIV WASHINGTON·Filed 1997·Granted Nov 30, 1999·2 cites·7 claims
- 3127US6638724B1BLNK proteinsUNIV WASHINGTON·Filed 1998·Granted Oct 28, 2003·0 cites·11 claims
Join the waitlist — get patent alerts
Get an alert when Andrew Chan files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →